Qian (Janie) Qin, MD, discusses the unique design of the phase 2 HARMONY trial of first-line niraparib plus abiraterone acetate and prednisone in mHSPC.
Qian (Janie) Qin, MD
Advertisement
Articles by Qian (Janie) Qin, MD
Qian (Janie) Qin, MD, discusses efforts to elucidate the optimal use of radium 223 plus enzalutamide in metastatic castration-resistant prostate cancer.
Qian (Janie) Qin, MD, discusses upcoming areas of interest in the renal cell carcinoma armamentarium.
Qian (Janie) Qin, MD, discusses the investigation and use of CAR T-cell therapy in patients with advanced clear cell renal cell carcinoma.
Qian (Janie) Qin, MD, discusses emerging treatment regimens for patients with advanced clear cell renal cell carcinoma.
Qian (Janie) Qin, MD, discusses several belzutifan combination strategies under investigation in advanced clear cell renal cell carcinoma.
Advertisement
Latest Updated Articles
Dr Qin on Ongoing Investigations of Radium-223 in mCRPCPublished: July 15th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Oncology Fellows Presents a New Drug Cheat Sheet for Fellows
3
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
4
Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant
5